Clinical Trials Directory

Trials / Unknown

UnknownNCT02305966

Evaluation of Implant Fixation in Reverse Total Shoulder Arthroplasty

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Reverse total shoulder replacement surgery (RTSA) is performed for individuals with advanced arthritis of the shoulder who also have tears in their rotator cuff muscles. A metal hemisphere is placed in the shoulder blade, and a plastic cup on a stem is placed in the upper arm. This orientation is opposite to the normal anatomy, giving rise to the term "reverse" shoulder replacement. While RTSA has a good clinical track record, no studies have examined how well fixed the implanted components are within patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgeryAll patients will receive a Delta XTEND reverse shoulder implant
DEVICE0.8 mm diameter Tantalum marker beadsAt the time of surgery, 0.8 mm diameter Tantalum marker beads will be injected into the bone surrounding the implant,

Timeline

Start date
2017-08-01
Primary completion
2018-12-01
Completion
2019-11-01
First posted
2014-12-03
Last updated
2017-03-24

Source: ClinicalTrials.gov record NCT02305966. Inclusion in this directory is not an endorsement.